Press release


Phost’in Therapeutics announces €2.5m funding from Bpifrance to support regulatory and early clinical development of its First-In-Class N-Glycosylation Inhibitor

Montpellier, France – Sept 2020, 11th
Read more

Phost'in Therapeutics strengthens management with appointment of veteran lifescience executives Dr. Alain Herrera and Pr. Bernard Pau

Montpellier, France – June 2020, 17th
Read more

Phost’in Therapeutics raises €10.3m to develop First-in-Class N-glycosylation Inhibitors for Cancer Treatment

Montpellier, France – April 2020, 20th
Read more

In the news


€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating – April 2020, 22nd
Read more

Phost'in Therapeutics normalise la glycosylation des cellules tumorales

Les Echos – April 2020, 24th
Read more

Phost’In Therapeutics lève 10,3 M€ et démarre une étude clinique contre le cancer

La Tribune – Objectif LR – April 2020, 22nd
Read more

Karine Chorro, entrepreneuse en quête de sens

Le Journal Toulousain, Nov. 2019, 14th
Read more